“the use of AmO (Amaranth Oil) instead of RaO may promote a proatherogenic lipid profile in obese and overweight inhabitants. “
Monika Dusâ€Zuchowska 1, Jaroslaw Walkowiak 1,*, Anna Morawska 2, Patrycja Krzyzanowska†Jankowska 1, Anna Miskiewiczâ€Chotnicka 1, Juliusz Przyslawski 2 and Aleksandra Lisowska 1 1 Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 60â€572 Poznan, Poland; monzuchowska@gmail.com (M.D.â€Z.); p.krzyzanowska81@gmail.com (P.K.â€J.); chotnicka@ump.edu.pl (A.M.â€C.); alisowska@ump.edu.pl (A.L.) 2 Department of Bromatology, Poznan University of Medical Sciences, 60â€354 Poznan, Poland; akm@ump.edu.pl (A.M.); jprzysla@ump.edu.pl (J.P.) * Correspondence: jarwalk@ump.edu.pl; Tel.: +48â€61849â€1432 Received: 13 November 2019; Accepted: 13 December 2019; Published: 16 December 2019